Bioniche Granted Patent for Oligonucleotide Technology
News Mar 17, 2006
Bioniche Life Sciences Inc. has announced that it has been granted a European patent - EP1432450 - covering the composition and use of an oligonucleotide family for the treatment of cancer entitled: "Therapeutically Useful Triethyleneglycol Cholesteryl Oligonucleotides", inventors Dr. Nigel C. Phillips, Dr. Mario C. Filion, and Dr. Andrea Herrera-Gayol.
Dr. Nigel C. Phillips, Chief Scientific Officer for Bioniche Life Sciences Inc. stated, "This patent consolidates our oligonucleotide patent portfolio. These oligonucleotides constitute a new composition family that enhances our ability to develop effective treatments for oncology indications."
"Bioniche now has technology platforms based on mycobacterial cell walls, unmodified oligonucleotides and modified oligonucleotides that have immune stimulant and anticancer activity."
"Bioniche is in a position to develop effective treatments for cancer using these unique and complementary technology platforms."
Graeme McRae, President & CEO of Bioniche Life Sciences Inc., commented, "The oligonucleotide platform is another example of Bioniche's ability to develop novel technologies."
"We plan to develop this platform through additional pre-clinical research in the immunomodulatory and anti-cancer areas and seek opportunities to partner the technology for further development."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
High Fruit and Veg Consumption May Reduce Breast Cancer RiskNews
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.READ MORE